Leukemia and Lymphoma

Leukemia and lymphoma research concentrates on these hematologic malignancies, seeking improved therapies and patient outcomes. Recent developments involve targeted therapies and immunotherapies, offering new hope for treatment. Minimal residual disease monitoring helps assess treatment effectiveness. Additionally, CAR-T cell therapy exhibits promise in treating both leukemia and lymphoma. This field aims to enhance treatment precision and minimize side effects while advancing the understanding of disease mechanisms, ultimately improving the prognosis for individuals with these blood cancers.

  • New therapies for leukemia and lymphoma.
  • Minimal residual disease monitoring.
  • CAR-T cell therapy in hematologic malignancies.

    Related Conference of Leukemia and Lymphoma

    Leukemia and Lymphoma Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in